Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (81)

2024

  1. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response

    Journal of Alzheimer's Disease, Vol. 98, Núm. 2, pp. 601-618

  2. Efficacy of Tamoxifen Metabolites in Combination with Colistin and Tigecycline in Experimental Murine Models of Escherichia coli and Acinetobacter baumannii

    Antibiotics, Vol. 13, Núm. 5

2023

  1. A metagenome-wide association study of HIV disease progression in HIV controllers

    iScience, Vol. 26, Núm. 7

  2. Anthelmintic Drugs for Repurposing against Gram-Negative Bacilli Infections

    Current Medicinal Chemistry, Vol. 30, Núm. 1, pp. 59-71

  3. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  4. In Vitro and In Vivo Virulence Study of Listeria monocytogenes Isolated from the Andalusian Outbreak in 2019

    Tropical Medicine and Infectious Disease, Vol. 8, Núm. 1

  5. In vitro and in vivo evaluation of two combined β-lactamase inhibitors against carbapenem-resistant Acinetobacter baumannii

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 11, pp. 1317-1325

  6. Role of blaTEM and OmpC in the piperacillin-tazobactam resistance evolution by E. coli in patients with complicated intra-abdominal infection

    Journal of Infection, Vol. 87, Núm. 3, pp. 220-229

2022

  1. Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections (Front. Microbiol., (2019), 10, (41), 10.3389/fmicb.2019.00041)

    Frontiers in Microbiology

  2. Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 1, pp. 14-21

  3. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

  4. Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test

    Emerging Microbes and Infections, Vol. 11, Núm. 1, pp. 2034-2044

2021

  1. AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections

    Frontiers in Microbiology, Vol. 12

  2. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  3. Editorial: Antivirulence Drugs Against Bacterial Infections

    Frontiers in Microbiology

  4. Efficacy of lysophosphatidylcholine as direct treatment in combination with colistin against acinetobacter baumannii in murine severe infections models

    Antibiotics, Vol. 10, Núm. 2, pp. 1-8

  5. Genomic characterization of host factors related to SARS-CoV-2 infection in people with dementia and control populations: The GR@ACE/DEGESCO study

    Journal of Personalized Medicine, Vol. 11, Núm. 12

  6. Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections

    Frontiers in Medicine, Vol. 8

  7. Potential tamoxifen repurposing to combat infections by multidrug-resistant gram-negative Bacilli

    Pharmaceuticals, Vol. 14, Núm. 6

  8. Repurposing of the tamoxifen metabolites to combat infections by multidrug-resistant gram-negative bacilli

    Antibiotics, Vol. 10, Núm. 3